SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001559053-23-000021
Filing Date
2023-07-10
Accepted
2023-07-10 16:11:29
Documents
12
Period of Report
2023-07-05
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K prta-20230705.htm   iXBRL 8-K 37514
  Complete submission text file 0001559053-23-000021.txt   173365

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prta-20230705.xsd EX-101.SCH 1917
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prta-20230705_lab.xml EX-101.LAB 25652
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prta-20230705_pre.xml EX-101.PRE 13538
6 EXTRACTED XBRL INSTANCE DOCUMENT prta-20230705_htm.xml XML 4446
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Filer) CIK: 0001559053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35676 | Film No.: 231079851
SIC: 2834 Pharmaceutical Preparations